| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |